Diversified Trust’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$155K Hold
11,932
﹤0.01% 1056
2026
Q1
$136K Hold
11,932
﹤0.01% 996
2025
Q4
$153K Buy
+11,932
New +$147K ﹤0.01% 993
2024
Q1
Sell
-16,970
Closed -$133K 837
2023
Q4
$133K Hold
16,970
﹤0.01% 816
2023
Q3
$124K Buy
+16,970
New +$141K ﹤0.01% 775
2022
Q1
Sell
-9,972
Closed -$275K 804
2021
Q4
$275K Buy
+9,972
New +$275K 0.01% 669
2021
Q1
Sell
-11,134
Closed -$171K 768
2020
Q4
$171K Buy
+11,134
New +$141K 0.01% 687

Other funds holding ANGO

Diversified Trust's ANGO Position: Q2 2026 in Review

Diversified Trust held its AngioDynamics (ANGO) position steady in Q2 2026 at 11,932 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #1056.

Diversified Trust first reported a position in ANGO in Q4 2020 and has held it in 7 quarters since. The position peaked at $275K in Q4 2021. 12 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Diversified Trust held 11,932 shares of AngioDynamics worth $155K as of Q2 2026.
  • Diversified Trust left its AngioDynamics share count unchanged in Q2 2026.
  • AngioDynamics made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #1056 holding.
  • Diversified Trust first reported a position in AngioDynamics in Q4 2020 and has held it in 7 quarters since.
  • Diversified Trust's AngioDynamics position peaked at $275K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.